Health News of Alabama: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health News of Alabama.

Press releases published on April 30, 2026

Apr. 30, 2026

Myriad Genetics National Survey: 88% of Patients with Depression and/or Anxiety Would Feel More Confident with a Personalized Mental Health Care Plan

Indeterminate GlobeNewswire

Apr. 30, 2026

Former Stryker Medical Division President Brad Saar Joins Sonablate Board to Support Growth of Non-Invasive Prostate Cancer Treatment

Indeterminate GlobeNewswire

Apr. 30, 2026

VIVUS Announces QSIVA® Price Reduction Across Nordics and Poland

Indeterminate GlobeNewswire

Apr. 30, 2026

VIVUS ogłasza obniżkę ceny produktu QSIVA® w krajach nordyckich i w Polsce

Indeterminate GlobeNewswire

Apr. 30, 2026

New York Blood Center Enterprises and Biohub Launch Collaboration to Advance Cord Blood–Derived Stem Cell Platforms

Indeterminate GlobeNewswire

Apr. 30, 2026

Glucotrack Announces Publication of Peer-Reviewed Study In The Journal of Diabetes Research Demonstrating Long-Term Accuracy and Stability of Continuous Blood Glucose Monitoring Technology

Indeterminate GlobeNewswire

Apr. 30, 2026

A.D.A.M. Innovations Enables Pharmacogenomics for NTT Precision Medicine

Indeterminate GlobeNewswire

Apr. 30, 2026

Fate Therapeutics Announces Data Presentation of FT819 Off-the-Shelf CAR T-Cell Product Candidate for Systemic Lupus Erythematosus (SLE) at the CCR – East 2026 Meeting

Indeterminate GlobeNewswire

Apr. 30, 2026

Alkeus Pharmaceuticals Announces Presentation of Gildeuretinol Data During the Association for Research in Vision and Ophthalmology (ARVO) 2026 Annual Meeting

Indeterminate GlobeNewswire

Apr. 30, 2026

Precision Neuroscience™ Partners With UChicago Medicine Researchers to Advance Brain–Computer Interface Research

Indeterminate GlobeNewswire

Apr. 30, 2026

FDA Grants Orchestra BioMed Additional Breakthrough Device Designation for AVIM Therapy

Indeterminate GlobeNewswire

Apr. 30, 2026

Ernexa Therapeutics Announces 1-for-25 Reverse Stock Split

Indeterminate GlobeNewswire

Apr. 30, 2026

AVITA Medical Names Cary Vance as Chief Executive Officer

Indeterminate GlobeNewswire

Apr. 30, 2026

Can-Fite Reports Positive Phase 2a Data with Namodenoson in Pancreatic Cancer; 35% of Patients Remain on Therapy, Including One Beyond 16 Months

Indeterminate GlobeNewswire

Apr. 30, 2026

Teva’s 2025 Healthy Future Report Highlights Environmental and Access to Medicines Progress, Including Meeting All Sustainability-Linked Bond Targets

Indeterminate GlobeNewswire

Apr. 30, 2026

VVT Med Announces Positive Clinical Data for ScleroSafe(R) Published in Peer-Reviewed Indian Journal of Vascular and Endovascular Surgery

Indeterminate GlobeNewswire

Apr. 30, 2026

EDAP TMS Strengthens Market Position with Landmark HIFI-2 Data Supporting Focal One® Robotic HIFU in Radiorecurrent Prostate Cancer

Indeterminate GlobeNewswire

Apr. 30, 2026

Kriya Announces Presentations at ASGCT 2026 Highlighting Advances Across Gene Therapy Platform

Indeterminate GlobeNewswire

Apr. 30, 2026

Pliant Therapeutics Announces First Patient Dosed in FORTIFY, the Phase 1b Indication Expansion Trial Evaluating PLN-101095 in Patients with ICI-Refractory Solid Tumors

Indeterminate GlobeNewswire

Apr. 30, 2026

Enlivex Treasury Portfolio Update: Listing of the RAIN Token on HTX, a Leading Cryptocurrency Exchange

Indeterminate GlobeNewswire